Abstract:Most cancers have lost a critical DNA damage response (DDR) pathway during tumor evolution. These alterations provide a useful explanation for the initial sensitivity of tumors to DNA-targeting chemotherapy. A striking example is dysfunctional homology-directed repair (HDR), e.g., due to inactivating mutations in BRCA1 and BRCA2 genes. Extensive efforts are being made to develop novel targeted therapies exploiting such an HDR defect. Inhibitors of poly(ADP-ribose) polymerase (PARP) are an instructive example of this approach. Despite the success of PARP inhibitors, the presence of primary or acquired therapy resistance remains a major challenge in clinical oncology. To move the field of precision medicine forward, we need to understand the precise mechanisms causing therapy resistance. Using preclinical models, various mechanisms underlying chemotherapy resistance have been identified. Restoration of HDR seems to be a prevalent mechanism but this does not explain resistance in all cases. Interestingly, some factors involved in DNA damage response (DDR) have independent functions in replication fork (RF) biology and their loss causes RF instability and therapy sensitivity. However, in BRCA-deficient tumors, loss of these factors leads to restored stability of RFs and acquired drug resistance. In this review we discuss the recent advances in the field of RF biology and its potential implications for chemotherapy response in DDR-defective cancers. Additionally, we review the role of DNA damage tolerance (DDT) pathways in maintenance of genome integrity and their alterations in cancer. Furthermore, we refer to novel tools that, combined with a better understanding of drug resistance mechanisms, may constitute a great advance in personalized diagnosis and therapeutic strategies for patients with HDR-deficient tumors.

Parental histone deposition on the replicated strands promotes error-free DNA damage tolerance and regulates drug resistance

Parental histone distribution at nascent strands controls homologous recombination during DNA damage tolerance

Defective transfer of parental histone decreases frequency of homologous recombination by increasing free histone pools in budding yeast

Structure and Mechanism of Human DNA Polymerase Η

Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability

Ctf4p Facilitates Mcm10p to Promote DNA Replication in Budding Yeast.

Mechanisms of DNA Damage Tolerance: Post-Translational Regulation of PCNA

Strand asymmetry of DNA damage tolerance mechanisms

The SPATA5-SPATA5L1 ATPase complex directs replisome proteostasis to ensure genome integrity

REV1 Coordinates a Multi-Faceted Tolerance Response to DNA Alkylation Damage and Prevents Chromosome Shattering in

Methylation and hydroxymethylation of cytosine alter efficiency of activity and fidelity of translesion DNA polymerases

Changes in the architecture and abundance of replication intermediates delineate the chronology of DNA damage tolerance pathways at UV-stalled replication forks in human cells

REV1 coordinates a multi-faceted tolerance response to DNA alkylation damage and prevents chromosome shattering in Drosophila melanogaster

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers

HLTF resolves G4s and promotes G4-induced replication fork slowing to maintain genome stability

USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication

Tau mediated coupling between Pol III synthesis and DnaB helicase unwinding helps maintain genomic stability

A replisome-associated histone H3-H4 chaperone required for epigenetic inheritance

HLTF Prevents G4 Accumulation and Promotes G4-induced Fork Slowing to Maintain Genome Stability

Probing DNA damage sites reveals context-dependent and novel DNA damage response factors

Histone deposition promotes recombination-dependent replication at arrested forks